| related words |
| melafind |
| soliris |
| increlex |
| erbitux |
| premarket |
| veridex |
| ferumoxytol |
| tablet |
| visudyne |
| investigational |
| qnexa |
| costar |
| pma |
| pinpoint |
| vantas |
| dosage |
| pralatrexate |
| velcade |
| feraheme |
| myvax |
|
| related documents |
| 855654--8/27/2010--IMMUNOGEN_INC |
| 855654--9/2/2008--IMMUNOGEN_INC |
| 855654--8/30/2007--IMMUNOGEN_INC |
| 874255--3/2/2009--MEDAREX_INC |
| 877902--3/16/2007--NEOSE_TECHNOLOGIES_INC |
| 1129425--2/29/2008--ZYMOGENETICS_INC |
| 1285819--3/31/2010--OMEROS_CORP |
| 901219--3/2/2010--HUMAN_GENOME_SCIENCES_INC |
| 901219--2/26/2009--HUMAN_GENOME_SCIENCES_INC |
| 872589--3/12/2007--REGENERON_PHARMACEUTICALS_INC |
| 874255--2/27/2008--MEDAREX_INC |
| 1028358--3/31/2008--GENITOPE_CORP |
| 1099414--3/16/2007--TANOX_INC |
| 877902--3/10/2008--NEOSE_TECHNOLOGIES_INC |
| 877902--3/8/2006--NEOSE_TECHNOLOGIES_INC |
| 872589--2/28/2006--REGENERON_PHARMACEUTICALS_INC |
| 353482--9/27/2006--VIRAGEN_INC |
| 911649--4/2/2007--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 1129425--3/1/2010--ZYMOGENETICS_INC |
| 1129425--3/6/2009--ZYMOGENETICS_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {regulation, government, change} |
| {capital, credit, financial} |
| {cost, operation, labor} |
| {stock, price, share} |
| {investment, property, distribution} |
| {operation, natural, condition} |
| {provision, law, control} |
| {financial, litigation, operation} |
| {competitive, industry, competition} |
| {operation, international, foreign} |
| {regulation, change, law} |
| {property, intellectual, protect} |
| {loss, insurance, financial} |
| {tax, income, asset} |
| {stock, price, operating} |
| {debt, indebtedness, cash} |
| {personnel, key, retain} |
| {interest, director, officer} |
|